Fig. 1From: Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancersMutations-testing results of 1714 patients with advanced non-small cell lung cancers.(multiple positive results 7EGFR&ALK, 1EGFR&ROS1, 2EGFR&KRAS, 2EGFR&BRAF, 2ALK&KRAS, 1ROS1&KRAS, 1EGFR&ROS1&KRAS)Back to article page